View in EDS HTML Full Text PDF Full Text

Omalizumab is effective and safe in chronic inducible urticaria (CIndU): Real‐world data from a large multi‐national UCARE study.

Saved in:
Bibliographic Details
Title: Omalizumab is effective and safe in chronic inducible urticaria (CIndU): Real‐world data from a large multi‐national UCARE study.
Authors: Soegiharto, R.1 (AUTHOR) r.soegiharto@umcutrecht.nl, Alizadeh Aghdam, M.1 (AUTHOR), Sørensen, J. A.2 (AUTHOR), van Lindonk, E.3 (AUTHOR), Bulut Demir, F.4 (AUTHOR), Mohammad Porras, N.5 (AUTHOR), Matsuo, Y.6 (AUTHOR), Kiefer, L.7,8 (AUTHOR), Knulst, A. C.1 (AUTHOR), Maurer, M.7,8 (AUTHOR), Ritchie, C.9 (AUTHOR), Rudenko, M.10 (AUTHOR), Kocatürk, E.7,11 (AUTHOR), Criado, R. F. J.12 (AUTHOR), Gregoriou, S.13 (AUTHOR), Bobylev, T.14 (AUTHOR), Kleinheinz, A.14 (AUTHOR), Takahagi, S.6 (AUTHOR), Hide, M.6,15 (AUTHOR), Giménez‐Arnau, A. M.5 (AUTHOR)
Source: Allergy. Feb2025, Vol. 80 Issue 2, p489-499. 11p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:01054538
DOI:10.1111/all.16334